A new clinical study published in the Annals of the Rheumatic Diseases found that adding the investigational drug clofutriben ...
A successful claim for PIP can now provide between £29.20 and £187.45 per week in additional financial support. Given that ...
GREEN BAY, Wis., Nov. 28, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Donald Massenburg, MD, Ph.D, FACP, FACR is recognized as a Pinnacle Lifetime Member for his contributions to ...
The most recent DWP statistics also indicate that over 3.8 million people in England and Wales are now claiming PIP. A ...
Nearly 1.2 million UK adults receive support for health conditions, with payments ranging from £116.80 to £749.80 every four ...
The FDA will submit a boxed warning and other labeling limits for Elevidys, an adeno-associated virus and vector-based gene ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
A dding an investigational drug called clofutriben to corticosteroid therapy could make the latter less toxic in long-term use, a pilot trial in patients with polymyalgia rheumatica (PMR) suggested.
No differences in remission achievement and relapse rates were seen among patients with giant cell arteritis receiving IVMP/MTX with lower-dose prednisone vs standard care. Researchers conducted a ...
Patricia Altschul tells all about her three marriages in her new book, Eat, Drink, and Remarry: Memories from a Lifetime of Art, Class, and Southern Charm. The Southern Charm star’s memoir, published ...
Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations for PMR treatment are not currently available. In this paper, we report the 2015 European ...
Background Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are often overlapping inflammatory diseases that occur in people older than 50 years. Both diseases can affect the quality of ...